Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Quantum Genesis AI (QTZM) Shares Outstanding (Diluted Average) (2024 - 2026)

Quantumzyme's Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $35.3 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) rose 0.6% year-over-year to $35.3 million; the TTM value through Jan 2026 reached $35.3 million, up 0.6%, while the annual FY2025 figure was $35.1 million, 1.08% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $35.3 million in Q1 2026 per QTZM's latest filing, down from $39.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $39.0 million in Q4 2025 to a low of $34.7 million in Q3 2024.
  • Average Shares Outstanding (Diluted Average) over 3 years is $35.7 million, with a median of $35.1 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): increased 12.15% in 2025, then grew 0.6% in 2026.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $34.7 million in 2024, then rose by 12.15% to $39.0 million in 2025, then decreased by 9.33% to $35.3 million in 2026.
  • Per Business Quant, the three most recent readings for QTZM's Shares Outstanding (Diluted Average) are $35.3 million (Q1 2026), $39.0 million (Q4 2025), and $35.1 million (Q3 2025).